Shanghai INT Medical Instruments Management

Management Kriterienprüfungen 2/4

Shanghai INT Medical Instruments CEO ist Dongke Liang , ernannt in Jun 2010, hat eine Amtszeit von 14.42 Jahren. Die jährliche Gesamtvergütung beträgt CN¥6.14M , bestehend aus 21.5% Gehalt und 78.5% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 6.84% der Aktien des Unternehmens, im Wert von HK$329.37M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.5 Jahre bzw. 4.2 Jahre.

Wichtige Informationen

Dongke Liang

Geschäftsführender

CN¥6.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	21.5%
Amtszeit als Geschäftsführer	14.4yrs
Eigentum des Geschäftsführers	6.8%
Durchschnittliche Amtszeit des Managements	5.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	4.2yrs

Jüngste Management Updates

Recent updates

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Jul 14

Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

May 17

Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Nov 26

Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Aug 16

Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Apr 24

Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

Apr 05

What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Mar 15

Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Jan 28

Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Dec 28

Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

Dec 02

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Dongke Liang im Vergleich zu den Einnahmen von Shanghai INT Medical Instruments verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	CN¥167m
Mar 31 2024	n/a	n/a	CN¥160m
Dec 31 2023	CN¥6m	CN¥1m	CN¥152m
Sep 30 2023	n/a	n/a	CN¥155m
Jun 30 2023	n/a	n/a	CN¥159m
Mar 31 2023	n/a	n/a	CN¥144m
Dec 31 2022	CN¥4m	CN¥1m	CN¥130m
Sep 30 2022	n/a	n/a	CN¥137m
Jun 30 2022	n/a	n/a	CN¥143m
Mar 31 2022	n/a	n/a	CN¥143m
Dec 31 2021	CN¥1m	CN¥625k	CN¥143m
Sep 30 2021	n/a	n/a	CN¥124m
Jun 30 2021	n/a	n/a	CN¥105m
Mar 31 2021	n/a	n/a	CN¥113m
Dec 31 2020	CN¥921k	CN¥891k	CN¥121m

Vergütung im Vergleich zum Markt: DongkeDie Gesamtvergütung ($USD846.92K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD465.81K).

Entschädigung vs. Einkommen: DongkeDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

Dongke Liang (46 yo)

14.4yrs

Amtszeit

CN¥6,140,000

Vergütung

Dr. Dongke Liang has been Executive Chairman of the Board at Shanghai INT Medical Instruments Co., Ltd. (formerly known as Shanghai Kindly Medical Instruments Co., Ltd.) since April 26, 2016 and also has b...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Dongke Liang	Executive Chairman of the Board & GM	14.4yrs	CN¥6.14m	6.84% HK$ 329.4m
Sen Lin	Executive Director	2.5yrs	CN¥1.01m	4.06% HK$ 195.4m
Yuan Song	Deputy GM	6.2yrs	CN¥1.03m	keine Daten
Zixiong Wu	Finance Controller	2.3yrs	keine Daten	keine Daten
Shui Bing Leung	Joint Company Secretary	5.5yrs	keine Daten	keine Daten

5.5yrs

Durchschnittliche Betriebszugehörigkeit

46yo

Durchschnittliches Alter

Erfahrenes Management: 1501Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.5 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Dongke Liang	Executive Chairman of the Board & GM	18.4yrs	CN¥6.14m	6.84% HK$ 329.4m
Sen Lin	Executive Director	2.5yrs	CN¥1.01m	4.06% HK$ 195.4m
Yuan Song	Deputy GM	2.5yrs	CN¥1.03m	keine Daten
Hung Kwan Hui	Independent Non-Executive Director	5.9yrs	CN¥120.00k	keine Daten
Huifang Ma	Chairperson of the Board of Supervisors	2.5yrs	keine Daten	keine Daten
Weixin Zhang	Non-Executive Director	5.9yrs	keine Daten	keine Daten
Hongqin Chen	Non-Executive Director	5.9yrs	keine Daten	keine Daten
Xigao Jian	Independent Non-Executive Director	5.9yrs	CN¥120.00k	keine Daten
Jie Chen	Supervisor	7.7yrs	keine Daten	keine Daten
Ruiqin Wang	Non-Executive Director	2.5yrs	CN¥799.00k	4.06% HK$ 195.4m
Congli Xu	Independent Non-Executive Director	2.5yrs	CN¥120.00k	keine Daten
Xiaoru Shen	Shareholder Representative Supervisor	2.5yrs	keine Daten	keine Daten

4.2yrs

Durchschnittliche Betriebszugehörigkeit

52.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 1501Die Vorstandsmitglieder gelten als erfahren (4.2 Jahre durchschnittliche Amtszeit).

Shanghai INT Medical Instruments Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Shanghai INT Medical Instruments Co., Ltd., Annual General Meeting, May 24, 2024

Shanghai INT Medical Instruments Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Shanghai Kindly Medical Instruments Co., Ltd. Approves Board Appointments

Less than half of directors are independent

Shanghai Kindly Medical Instruments Co., Ltd., Annual General Meeting, May 16, 2022

Recent updates

First half 2024 earnings released: EPS: CN¥0.58 (vs CN¥0.48 in 1H 2023)

Shanghai INT Medical Instruments Co., Ltd. to Report Q2, 2024 Results on Aug 19, 2024

Shanghai INT Medical Instruments Co., Ltd. Approves Final Dividend for the Year Ended December 31, 2023, Payable on or About, 28 June 2024

Upcoming dividend of HK$0.30 per share

Shanghai INT Medical Instruments Co., Ltd., Annual General Meeting, May 24, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shanghai INT Medical Instruments Co., Ltd., Annual General Meeting, May 24, 2024

New minor risk - Shareholder dilution

Shanghai INT Medical Instruments Co., Ltd. Proposes Ordinary Final Cash Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024

Dividend of HK$0.30 announced

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shanghai INT Medical Instruments Co., Ltd. to Report Fiscal Year 2023 Results on Mar 18, 2024

New major risk - Earnings quality

First half 2023 earnings released: EPS: CN¥0.48 (vs CN¥0.30 in 1H 2022)

Shanghai Kindly Medical Instruments Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023

Shanghai Kindly Medical Instruments Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on or About 28 June 2023

Upcoming dividend of HK$0.27 per share at 1.0% yield

Full year 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Now 20% undervalued

First half 2022 earnings released: EPS: CN¥0 (vs CN¥0.30 in 1H 2021)

Investor sentiment improved over the past week

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Investor sentiment improved over the past week

Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Kindly Medical Instruments Co., Ltd. Approves Board Appointments

Upcoming dividend of HK$0.32 per share

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.86 (vs CN¥0.73 in FY 2020)

Shanghai Kindly Medical Instruments Co., Ltd., Annual General Meeting, May 16, 2022

Investor sentiment deteriorated over the past week

Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Investor sentiment deteriorated over the past week

Shanghai Kindly Medical Instruments Co., Ltd. Announces First Patient Implantation of Hanchorvalve Clinical Trial

Investor sentiment improved over the past week

First half 2021 earnings released: EPS CN¥0.30 (vs CN¥0.41 in 1H 2020)

Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Investor sentiment improved over the past week

Upcoming dividend of HK$0.34 per share

Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

Investor sentiment deteriorated over the past week

Shanghai Kindly Medical Instruments Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2020, Payable on or about 21 June 2021

Full year 2020 earnings released

Shanghai Kindly Medical Instruments Co., Ltd., Annual General Meeting, May 17, 2021

What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Shanghai Kindly Medical Instruments Co., Ltd. to Report Fiscal Year 2020 Results on Mar 19, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: HK$33.55

Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Investor sentiment deteriorated over the past week

New 90-day low: HK$37.10

Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

Market pulls back on stock over the past week

New 90-day low: HK$43.50

New 90-day low: HK$46.80

First half earnings released

Shanghai Kindly Medical Instruments Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit